MSN LABORATORIES EUROPE LIMITED — Atorvastatin Importer Profile
Pharmaceutical Importer · #14 buyer for Atorvastatin · $13.4M import value · 539 shipments · UNITED KINGDOM · DGFT Verified
MSN LABORATORIES EUROPE LIMITED is the #14 importer of Atorvastatin from India with $13.4M in import value and 539 verified shipments. MSN LABORATORIES EUROPE LIMITED holds a 1.3% market share in Atorvastatin imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 65 formulations shipped to 1 country.
MSN LABORATORIES EUROPE LIMITED — Atorvastatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Atorvastatin to MSN LABORATORIES EUROPE LIMITED?
Verified from 539 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MSN LABORATORIES PRIVATE LIMITED | $13.4M | 539 | 100.0% |
MSN LABORATORIES EUROPE LIMITED sources Atorvastatin from 1 verified Indian supplier based on 539 customs records. The primary supplier is MSN LABORATORIES PRIVATE LIMITED accounting for 100.0% of imports.
How Does MSN LABORATORIES EUROPE LIMITED Compare to Nearest Atorvastatin Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $14.7M | 663 | $22.1K |
| 11 | ICS (BIOCON PHARMA INC) | UNITED STATES | $9.8M | 196 | $50.0K |
| 14 | MSN LABORATORIES EUROPE LIMITED ★ | UNITED KINGDOM | $9.5M | 227 | $41.6K |
| 5 | LIFESCIENCE LOGISTICS | UNITED STATES | $6.7M | 133 | $50.0K |
| 12 | MYLAN PHARMACEUTICALS INC | UNITED STATES | $6.5M | 129 | $50.0K |
MSN LABORATORIES EUROPE LIMITED ranks #14 among 1,291 Atorvastatin importers from India. Average shipment value of $41.6K compared to the market average of $117.9K. The closest competitors by value are YUSEN LOGISTICS BENELUX BELGIUM and ICS (BIOCON PHARMA INC).
Where Does MSN LABORATORIES EUROPE LIMITED Import Atorvastatin To?
Destination countries from 539 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $13.4M | 539 | 100.0% |
MSN LABORATORIES EUROPE LIMITED imports Atorvastatin to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $13.4M.
What Atorvastatin Formulations Does MSN LABORATORIES EUROPE LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| ATORVASTATIN TAB 40 MG X 28'S MSN UK | $3.4M | 145 |
| ATORVASTATIN TAB 20 MG X 28'S MSN UKNOS | $1.9M | 51 |
| ATORVASTATIN TAB 80 MG X 28'S MSN UK | $1.8M | 91 |
| ATORVASTATIN TAB 20 MG X 28'S MSN UK | $1.5M | 52 |
| ATORVASTATIN TAB 10 MG X 28'S MSN UK | $911.8K | 27 |
| ATORVASTATIN TAB 40 MG X 28'S MSN UKNOS | $505.7K | 20 |
| ATORVASTATIN TAB 20 MG X 28S MSN UKNOS | $300.0K | 6 |
| ATORVASTATIN TAB 10 MG X 28'S MSN UKNOS | $223.9K | 6 |
| ATORVASTATIN TAB 20MG X 28'S MSN UK | $207.6K | 6 |
| ATORVASTATIN TAB 40MG X 28'S MSN UK | $205.3K | 7 |
MSN LABORATORIES EUROPE LIMITED imports 65 distinct Atorvastatin formulations from India. The top formulation is ATORVASTATIN TAB 40 MG X 28'S MSN UK with 145 shipments worth $3.4M.
Regulatory Requirements: Importing Atorvastatin into United Kingdom
What MSN LABORATORIES EUROPE LIMITED and other importers must comply with to import Atorvastatin from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Atorvastatin
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Atorvastatin from India and How Much Does MSN LABORATORIES EUROPE LIMITED Import?
India exported $152.2M worth of Atorvastatin through 15,000 shipments from 477 suppliers to 145 countries, serving 1,291 buyers globally. MSN LABORATORIES EUROPE LIMITED imports $13.4M of this total, accounting for 1.3% of India's Atorvastatin exports with 539 shipments from UNITED KINGDOM. This is verified from 539 customs shipment records covering 65 distinct formulations.
What Is the Average Order Value for MSN LABORATORIES EUROPE LIMITED's Atorvastatin Imports?
MSN LABORATORIES EUROPE LIMITED's average Atorvastatin order value is $24.9K per consignment, based on 539 shipments totaling $13.4M. MSN LABORATORIES EUROPE LIMITED is based in UNITED KINGDOM and ranks #14 among all Atorvastatin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Atorvastatin to MSN LABORATORIES EUROPE LIMITED?
MSN LABORATORIES EUROPE LIMITED sources Atorvastatin from 1 verified Indian supplier: MSN LABORATORIES PRIVATE LIMITED ($13.4M, 100.0%). This is based on 539 customs records.
How Does MSN LABORATORIES EUROPE LIMITED Compare to Other Atorvastatin Importers?
MSN LABORATORIES EUROPE LIMITED ranks #14 among 1,291 Atorvastatin importers from India with a 1.3% market share. The top 3 importers are APL SWIFT SERVICES (MALTA) LTD., ($25.9M), APOTEX CORP ($21.4M), NOVADOZ PHARMACEUTICALS LLC ($17.3M). MSN LABORATORIES EUROPE LIMITED processed 539 shipments from UNITED KINGDOM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atorvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MSN LABORATORIES EUROPE LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MSN LABORATORIES EUROPE LIMITED's capped import value divided by total capped export value for Atorvastatin across all Indian exporters.
- 5.Verified Records: This page is backed by 539 individual customs records matching MSN LABORATORIES EUROPE LIMITED importing Atorvastatin, covering 65 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 145+ countries, 1,291+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Atorvastatin Import Data for MSN LABORATORIES EUROPE LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for MSN LABORATORIES EUROPE LIMITED's Atorvastatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN LABORATORIES EUROPE LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
MSN LABORATORIES EUROPE LIMITED × Atorvastatin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MSN LABORATORIES EUROPE LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atorvastatin. For current order-level data, contact TransData Nexus.